Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannu Alho

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Journal of Studies on Alcohol and Drugs|November 1, 2013
Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexoneSalla Vuoristo-Myllys, Jari Lahti, Hannu Alho, et al.
Drug and Alcohol Dependence|April 13, 2016
Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patientsEssiina Launonen, Isla Wallace, Elina Kotovirta, et al.
The International Journal on Drug Policy|May 3, 2015
Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patientsEssiina Launonen, Hannu Alho, Elina Kotovirta, et al.
Archives of Internal Medicine|April 3, 2002
Opposite associations of carbohydrate-deficient transferrin and gamma-glutamyltransferase with prevalent coronary heart diseasePekka Jousilahti, Erkki Vartiainen, Hannu Alho, et al.
International Journal of Mental Health and Addiction|May 28, 2013
Characteristics of Treatment Seeking Finnish Pathological Gamblers: Baseline Data from a Treatment StudyTuuli Lahti, Jukka Halme, Maiju Pankakoski, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 30, 2007
A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependenceE Laaksonen, A Koski-Jännes, M Salaspuro, et al.
Addictive Behaviors|May 12, 2004
Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrinAnnukka Merikallio-Pajunen, Nuria Strid, Antti Suokas, et al.
Clinical Biochemistry|March 11, 2009
Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patientsMarika Crohns, Seppo Saarelainen, Marina Erhola, et al.
Substance Abuse Treatment, Prevention, and Policy|April 17, 2015
At-risk and problem gambling among adolescents: a convenience sample of first-year junior high school students in FinlandSari Castrén, Marjut Grainger, Tuuli Lahti, et al.
Psychopharmacology Bulletin|December 15, 2010
Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot studyTuuli Lahti, Jukka T Halme, Maiju Pankakoski, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Journal of Studies on Alcohol and Drugs|November 1, 2013
Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexoneSalla Vuoristo-Myllys, Jari Lahti, Hannu Alho, et al.
Drug and Alcohol Dependence|April 13, 2016
Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patientsEssiina Launonen, Isla Wallace, Elina Kotovirta, et al.
The International Journal on Drug Policy|May 3, 2015
Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patientsEssiina Launonen, Hannu Alho, Elina Kotovirta, et al.
Archives of Internal Medicine|April 3, 2002
Opposite associations of carbohydrate-deficient transferrin and gamma-glutamyltransferase with prevalent coronary heart diseasePekka Jousilahti, Erkki Vartiainen, Hannu Alho, et al.
International Journal of Mental Health and Addiction|May 28, 2013
Characteristics of Treatment Seeking Finnish Pathological Gamblers: Baseline Data from a Treatment StudyTuuli Lahti, Jukka Halme, Maiju Pankakoski, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 30, 2007
A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependenceE Laaksonen, A Koski-Jännes, M Salaspuro, et al.
Addictive Behaviors|May 12, 2004
Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrinAnnukka Merikallio-Pajunen, Nuria Strid, Antti Suokas, et al.
Clinical Biochemistry|March 11, 2009
Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patientsMarika Crohns, Seppo Saarelainen, Marina Erhola, et al.
Substance Abuse Treatment, Prevention, and Policy|April 17, 2015
At-risk and problem gambling among adolescents: a convenience sample of first-year junior high school students in FinlandSari Castrén, Marjut Grainger, Tuuli Lahti, et al.
Psychopharmacology Bulletin|December 15, 2010
Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot studyTuuli Lahti, Jukka T Halme, Maiju Pankakoski, et al.
Pageof 10